Dear Editor,We report the case of a 68-year-old man who presented at the emergency department with abdominal pain, vomiting, and constipation that progressively became worse over a 1-month period. His social history was notable for a remote phase of smoking. On physical examination, the patient was found to be hemodynamically stable, and his abdomen was tender with diffuse periumbilical pain on palpation. His laboratory results showed hemoglobin of 12.4 g/dL (normal, >13 g/dL), white blood count of 13000/ uL (normal, 4000-11000/uL), and C-reactive protein level of 96.4 mg/L (normal, <2.9 mg/L). Abdominal computerized tomography (CT) scan revealed focal thickening of the ileal segment ( Figure 1a). Additional thoracic CT revealed a left upper lobe mass (50Ă55 mm) ( Figure 1b). The patient underwent bronchofibroscopy and an exploratory laparoscopy with enterectomy. The cytology of the bronchial aspirate and histology of the ileal enterectomy were consistent with squamous cell carcinoma of the lung with intestinal metastasis, respectively (Figure 2a, 2b, respectively). The neoplasia was completely staged as squamous cell carcinoma of the lung, stage IV cT2b-N2M1b (mediastinal and left hilar lymph nodes and liver metastases) according to the 7th edition of TNM classification (1). The patient was treated with palliative chemotherapy with carboplatin and gemcitabine (6 cycles) and died 6 months after the diagnosis.Lung cancer is one of the most common cancers worldwide and is the leading cause of cancer-related deaths with a 5-year survival of 10%-25% (2). In non-small-cell lung cancers (NSCLC), approximately 40% of the patients have metastatic disease at the time of presen-tation (1). NSCLC can metastasize to nearly any organ, but it usually spreads to the brain, liver, adrenal glands, bone, and lung. Clinically significant small bowel metastases are rare (frequency of 0.5%) (2), and its diagnosis is usually based on post-mortem examination [12% of prevalence of gastrointestinal (GI) metastases and 8.1% in small bowel] (3). Small bowel, especially ileum, is the most commonly reported site for GI-tract metastasis of lung cancer. Small bowel metastases may occur in every cell type of primary lung cancer. The pathogenesis of small bowel metastases has been thought to be due to tumor cell spread via the hematogenous and lymphatic routes. Tumor invasion of the bowel wall results in perforation, obstruction, and bleeding. It appears that perforation or hemorrhage can also occur in patients under chemotherapy because chemotherapy may lead to tumor necrosis and acute ulceration (4). The difficulty in early detection of GI metastases leads to a delay in diagnosis until presenting with life-threatening complications that frequently require emergency surgeries (4). The time between the diagnosis of squamous cell carcinoma of the lung and the discovery of GI metastases is extremely variable, occurring more often in the first 12 months (2,4).In this case report, small bowel obstruction was the initial clinical symptom for this pat...